The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dudley, M. E., Wunderlich, J. R., Yang, J. C., Sherry, R. M., Topalian, S. L., Restifo, N. P., Royal, R. E., Kammula, U., White, D. E., Mavroukakis, S. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.240 · Cited by 1,639
Rosenberg, S. A., & Dudley, M. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405730101 · Cited by 364
A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients
Bleumer, I., Knuth, A., Oosterwijk, E., Hofmann, R., Varga, Z., Lamers, C., Kruit, W., Melchior, S., Mala, C., Ullrich, S., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601617 · Cited by 173
Self-citationDivgi, C. R., O’Donoghue, J. A., Welt, S., O'Neel, J., Finn, R., Motzer, R. J., Jungbluth, A. A., Hoffman, E. W., Ritter, G., Larson, S. M., et al. (2004) · PubMed · Cited by 103
Brouwers, A. H., Mulders, P., Mulder, P. H. M. D., van den Broek, W. J. M., Buijs, W. C. A. M., Mala, C., Joosten, F. B. M., Oosterwijk, E., Boerman, O. C., Corstens, F. H. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.732 · Cited by 82
Self-citationLamers, C. H. J., Willemsen, R. A., Luider, B. A., et al. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700477 · Cited by 73
Self-citationSteffens, M. G., Boerman, O. C., Oyen, W. J. G., et al. (1999) · PubMed · Cited by 45
Lamers, C. H. J., Gratama, J. W., Pouw, N. M. C., Langeveld, S. C. L., Krimpen, B. A. V., Kraan, J., Stoter, G., & Debets, R. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1452 · Cited by 40
Self-citation
Cited by
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Chimeric antigen receptor T-cell therapy—assessment and management of toxicities
Neelapu, S. S., Tummala, S., Kebriaei, P., Wierda, W., Gutierrez, C., Locke, F. L., Komanduri, K. V., Lin, Y., Jain, N., Daver, N., et al. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.148 · Cited by 2,438
Kalos, M., Levine, B. L., Porter, D. L., Katz, S., Grupp, S. A., Bagg, A., & June, C. H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002842 · Cited by 2,388
Porter, D. L., Hwang, W.-T., Frey, N. V., Lacey, S. F., Shaw, P. A., Loren, A. W., Bagg, A., Marcucci, K. T., Shen, A., Gonzalez, V., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac5415 · Cited by 1,729
Toxicities of chimeric antigen receptor T cells: recognition and management
Brudno, J. N., & Kochenderfer, J. N. (2016) · Blood · doi:10.1182/blood-2016-04-703751 · Cited by 1,283
Metadata
- Authors
- Lamers, C. H. J., Sleijfer, S., Vulto, A. G., Kruit, W. H. J., Kliffen, M., Debets, R., Gratama, J. W., Stoter, G., & Oosterwijk, E.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-05-01
- Volume
- 24
- Issue
- 13
- Pages
- e20-e22
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2136100686
- Cited by
- 915
- References
- 8
- FWCI
- 17.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience. https://app.cochat.ai/papers/10.1200/jco.2006.05.9964
- The paper
- Lamers, C. H. J., Sleijfer, S., Vulto, A. G., Kruit, W. H. J., Kliffen, M., Debets, R., Gratama, J. W., Stoter, G., & Oosterwijk, E. (2006). Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2006.05.9964
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
